Related Experiment Video
Updated: Dec 25, 2025

Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
Diagnostic value of pentraxin 3 in respiratory tract infections: A meta-analysis
Wu Ye1, Qing-Dong Huang, Ting-Yu Tang
1Department of Respiratory Diseases, Zhejiang Hospital, Hangzhou, Zhejiang Province, People's Republic of China.
Background:
Pentraxin 3 is an acute inflammatory protein of the long pentraxin subfamily. A meta-analysis was performed to assess diagnostic accuracy of pentraxin 3 for respiratory tract infections.
Methods:
We identify studies examining diagnostic value of pentraxin 3 for respiratory tract infections by searching Pubmed, Web of Knowledge, and Cochrane Library. The sensitivity, specificity, negative likelihood ratio (LR), positive LR, and diagnostic odds ratio were pooled. The area under the summary receiver operator characteristic (SROC) curve and Q point value (Q*) were calculated.
Results:
A total of 8 studies with 961 individuals were eligible for this meta-analysis. The pooled sensitivity of pentraxin 3 in diagnosis of respiratory tract infections was 0.78, the pooled specificity was 0.73, the area under the SROC curve was 0.84, and the Q* was 0.77. The area under the SROC curve of serum and bronchoalveolar lavage fluid (BALF) pentraxin 3 was 0.85 and 0.89, respectively. Meta-regression analysis revealed that cutoff value was the source of heterogeneity among the included studies. The Deek funnel plot test suggested no evidence of publication bias. Subgroup analyses showed that the area under the SROC curve of pentraxin 3 in diagnosis of ventilator-associated pneumonia (VAP) was 0.89.
Conclusion:
Pentraxin 3 has a moderate accuracy for diagnosing respiratory tract infections and VAP. The overall diagnostic value of BALF level of pentraxin 3 is superior to its serum concentration.
Insights
Pentraxin 3 shows moderate accuracy in diagnosing respiratory tract infections and ventilator-associated pneumonia. Bronchoalveolar lavage fluid levels offer superior diagnostic value compared to serum concentrations for these infections.
Area of Science:
- Biochemistry
- Medical Diagnostics
- Infectious Diseases
Background:
- Pentraxin 3 is an acute phase protein belonging to the long pentraxin subfamily.
- It plays a role in the innate immune system response to inflammation.
Purpose of the Study:
- To evaluate the diagnostic accuracy of Pentraxin 3 for respiratory tract infections through a meta-analysis.
- To compare the diagnostic utility of Pentraxin 3 in different sample types, such as serum and bronchoalveolar lavage fluid (BALF).
Main Methods:
- A systematic literature search was conducted across major databases (PubMed, Web of Knowledge, Cochrane Library).
- Diagnostic performance metrics including sensitivity, specificity, likelihood ratios, and diagnostic odds ratio were pooled.
- Summary receiver operator characteristic (SROC) curves and Q* values were calculated to assess overall accuracy.
Main Results:
- The meta-analysis included 8 studies with 961 participants.
- Pooled sensitivity and specificity for Pentraxin 3 in diagnosing respiratory tract infections were 0.78 and 0.73, respectively.
- The area under the SROC curve was 0.84, with higher values for BALF (0.89) compared to serum (0.85). The diagnostic accuracy for ventilator-associated pneumonia (VAP) was 0.89.
Conclusions:
- Pentraxin 3 demonstrates moderate diagnostic accuracy for respiratory tract infections and VAP.
- Bronchoalveolar lavage fluid levels of Pentraxin 3 provide superior diagnostic value compared to serum concentrations.
- Cutoff value was identified as a source of heterogeneity in diagnostic accuracy.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
10:35Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Pneumothorax-II
Clinical Manifestations:
Acute Pyelonephritis II: Diagnostic Studies and Management
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...